Processa Pharmaceuticals Other Long Term Liabilities (Quarterly) Analysis

Processa Pharmaceuticals, Inc. (PCSA)

1.93 +0.08 (+4.32%) USD | NASDAQ | Feb 24, 14:10

View Other Long Term Liabilities (Quarterly) for PCSA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Kodiak Sciences, Inc.	Upgrade
Pyxis Oncology, Inc.	--
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade